Selz Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Selz Capital’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$610K	Buy	+12,959	New	+$374K	0.11%	58

Other funds holding CNST

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Selz Capital's CNST Position: Q4 2019 in Review

Selz Capital opened a new position in Constellation Pharmaceuticals, Inc. (CNST) in Q4 2019: 12,959 shares worth $610K. The stake represents 0.11% of the portfolio and ranks #58 among its holdings.

100 funds tracked by Wall St. Rank hold CNST as of Q4 2019.

Selz Capital held 12,959 shares of Constellation Pharmaceuticals, Inc. worth $610K as of Q4 2019.
Constellation Pharmaceuticals, Inc. was a new Selz Capital position in Q4 2019.
Constellation Pharmaceuticals, Inc. made up 0.11% of Selz Capital's portfolio in Q4 2019, its #58 holding.
100 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2019.

Based on Selz Capital's 13F filing for Q4 2019, filed 16 Jan 2020.